Synopsis: The U.S. Food and Drug Administration announced it is investigating a possible death risk for TG Therapeutics’ Ukoniq (umbralisib). The drug…
Children
-
-
GileadGlobal MarketPatentsRegulatory
Gilead’s Strong Financials Marred by $1.25B ViiV Patent Settlement
by adminby adminSummary : This week, Gilead Sciences took a $1.25 billion hit after reaching a settlement with ViiV Healthcare on a patent dispute…
-
Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine;…
-
Global MarketRegulatoryU.S FDA
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
by adminby adminSynopsis : The U.S. Food and Drug Administration, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organizations have partnered…
-
AgrochemicalsGlobal Market
Allarity Therapeutics and Oncoheroes Biosciences Sign Agreements to Advance Pediatric Cancer Development of Dovitinib and Stenoparib
by adminby adminSummary ; -Oncoheroes will fund and advance the clinical development of both dovitinib and stenoparib in pediatric cancers, utilizing Allarity’s DRP® companion…
-
CompaniesNovartisRegulatoryU.S FDA
Novartis Cosentyx® Receives FDA Approval for the Treatment of Children and Adolescents with Enthesitis-Related Arthritis and Psoriatic Arthritis
by adminby adminSummary : -New approvals are based on JUNIPERA trial data showing Cosentyx® (secukinumab) demonstrated reduced flare risk versus placebo and improvement in…
-
CompaniesPfizerPharma Science & Research
Swissmedic Approves Pfizer/ BioNTech Vaccine for Children Over 5
by adminby adminSummary: The clinical trial results show that the vaccine is safe and effective in this in this age group, it will thus…
-
Synopsis: The FDA’s authorization expands the drug’s use to fight Covid-19 to people under the age of 12 The therapy, Bamlanivimab plus…
-
CompaniesPfizerPharma Science & ResearchTGA
TGA Provisionally Approves Pfizer Vaccine for Children aged 5-11 yrs
by adminby adminSynopsis: The Therapeutic Goods Administration has provisionally approved the Comirnaty (Pfizer) vaccine as safe and effective for use among 5 to 11-year-old…
-
Agrochemicals
Pfizer-BioNTech became the First FDA Authorized COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age
by adminby adminKEYPOINTS FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age. Effectiveness: Immune responses of children…